Among women with a previous diagnosis of early state breast cancer, just 3 to 4 alcholic drinks per week could increase their risk for disease recurrence and death, especially if they are postmenopausal, overweight or obese.
Among women with a previous diagnosis of early-stage breast cancer, just 3 to 4 alcoholic drinks per week could increase their risks for disease recurrence and death, especially if they are postmenopausal, overweight, or obese.
Researchers administered a survey on alcohol use to 1,897 early-stage breast cancer survivors diagnosed during 1997 to 2000 who participated in the Life After Cancer Epidemiology study. The researchers then followed the participants for an average of about 7 years. Compared with no drinking, the authors of the study determined that consuming 6 g per day or more of alcohol was associated with an increased risk for breast cancer recurrence (HR, 1.35; 95% CI, 1.00-1.83) and death because of breast cancer (HR, 1.51; 95% CI, 1.00-2.29). Recurrence risk was higher for postmenopausal women (HR, 1.51; 95% CI, 1.05-2.19) and women who were overweight or obese (HR, 1.60; 95% CI, 1.08-2.38).
However, alcohol consumption was not associated with all-cause death and was possibly associated with a decreased risk for non-breast cancer death, alluding to its cardioprotective effects.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More